345 related articles for article (PubMed ID: 25580789)
1. Resolution of a case of pediatric pemphigus vulgaris treated with rituximab.
Didona D; Paolino G; Donati M; Caposeina D; Calvieri S; Didona B
Acta Dermatovenerol Croat; 2014; 22(4):288-90. PubMed ID: 25580789
[TBL] [Abstract][Full Text] [Related]
2. Rituximab Therapy for Childhood Pemphigus Vulgaris.
Kincaid L; Weinstein M
Pediatr Dermatol; 2016; 33(2):e61-4. PubMed ID: 26765543
[TBL] [Abstract][Full Text] [Related]
3. Clinical resolution of pemphigus vulgaris on rituximab.
Cusick E; Silverstein D
Dermatol Online J; 2017 Sep; 23(9):. PubMed ID: 29469734
[TBL] [Abstract][Full Text] [Related]
4. Management of pediatric pemphigus vulgaris with rituximab: A case report and review of the literature.
Mistry BD; Leis M; Lee DM; Levy R
Pediatr Dermatol; 2022 Nov; 39(6):960-966. PubMed ID: 35871636
[TBL] [Abstract][Full Text] [Related]
5. Crescendo response to rituximab in oral pemphigus vulgaris: a case with 7-year follow-up.
Greenblatt DT; Benton EC; Groves RW; Setterfield JF
Clin Exp Dermatol; 2016 Jul; 41(5):529-32. PubMed ID: 27061201
[TBL] [Abstract][Full Text] [Related]
6. Childhood pemphigus vulgaris successfully treated with rituximab.
Kanwar AJ; Sawatkar GU; Vinay K; Hashimoto T
Indian J Dermatol Venereol Leprol; 2012; 78(5):632-4. PubMed ID: 22960821
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of rituximab therapy in patients with pemphigus vulgaris: first report from Turkey.
Uzun S; Bilgiç Temel A; Akman Karakaş A; Ergün E; Özkesici B; Eskiocak AH; Erat A; Uğurlu N; Nazlım B; Koç S; Bozkurt S; Dicle Ö; Alpsoy E; Yılmaz E
Int J Dermatol; 2016 Dec; 55(12):1362-1368. PubMed ID: 27653507
[TBL] [Abstract][Full Text] [Related]
8. Rituximab therapy in pediatric pemphigus patients: A retrospective analysis of five Turkish patients and review of the literature.
Bilgic-Temel A; Özgen Z; Harman M; Kapıcıoğlu Y; Uzun S
Pediatr Dermatol; 2019 Sep; 36(5):646-650. PubMed ID: 31355479
[TBL] [Abstract][Full Text] [Related]
9. Rituximab in refractory pemphigus vulgaris.
Sorce M; Aricò M; Bongiorno MR
Dermatol Ther; 2008 Jul; 21 Suppl 1():S6-9. PubMed ID: 18727815
[TBL] [Abstract][Full Text] [Related]
10. Rituximab in childhood pemphigus vulgaris: a long-term follow-up case and review of the literature.
Fuertes I; Guilabert A; Mascaró JM; Iranzo P
Dermatology; 2010 Aug; 221(1):13-6. PubMed ID: 20389028
[TBL] [Abstract][Full Text] [Related]
11. Nasal, pharyngeal, and laryngeal pemphigus vulgaris successfully treated with rituximab.
Sami N
Ear Nose Throat J; 2017; 96(4-5):E35-E38. PubMed ID: 28489243
[TBL] [Abstract][Full Text] [Related]
12. Long-term prognosis of pemphigus in Korea: retrospective analysis of 199 patients.
Kim MR; Kim HC; Kim SC
Dermatology; 2011; 223(2):182-8. PubMed ID: 22025028
[TBL] [Abstract][Full Text] [Related]
13. Rituximab therapy in severe juvenile pemphigus vulgaris.
Mamelak AJ; Eid MP; Cohen BA; Anhalt GJ
Cutis; 2007 Oct; 80(4):335-40. PubMed ID: 18038698
[TBL] [Abstract][Full Text] [Related]
14. Rituximab for treatment-refractory pemphigus and pemphigoid: a case series of 17 patients.
Kasperkiewicz M; Shimanovich I; Ludwig RJ; Rose C; Zillikens D; Schmidt E
J Am Acad Dermatol; 2011 Sep; 65(3):552-558. PubMed ID: 21641080
[TBL] [Abstract][Full Text] [Related]
15. Comparing early and late treatments with rituximab in pemphigus vulgaris: which one is better?
Balighi K; Daneshpazhooh M; Mahmoudi H; Badakhsh M; Teimourpour A; Ehsani AH; Azizpour A; Akbari Z; Mahdavinia M; Ghasemiadl M; Tavakolpour S
Arch Dermatol Res; 2019 Jan; 311(1):63-69. PubMed ID: 30506422
[TBL] [Abstract][Full Text] [Related]
16. [Rituximab induced remission of pemphigus vulgaris: 2 cases].
Borel C; Launay F; Garrouste C; Astudillo L; Bazex J; Arlet P; Paul C; Viraben R; Sailler L
Rev Med Interne; 2007 Apr; 28(4):266-8. PubMed ID: 17188405
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of severe refractory pemphigus vulgaris with rituximab].
Pitarch G; Sánchez-Carazo JL; Pardo J; Torrijos A; Roche E; Fortea JM
Actas Dermosifiliogr; 2006; 97(1):48-51. PubMed ID: 16540052
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the Effects of Rituximab Monotherapy on Different Subsets of Circulating T-Regulatory Cells and Clinical Disease Severity in Severe Pemphigus Vulgaris.
Bhattacharjee R; De D; Handa S; Minz RW; Saikia B; Joshi N
Dermatology; 2016; 232(5):572-577. PubMed ID: 27576321
[TBL] [Abstract][Full Text] [Related]
19. Childhood pemphigus foliaceus presenting as a polycyclic eruption: Case report and review of the literature.
Evans MS; Culton DA; Diaz LA; Googe PB; Morrell DS
Pediatr Dermatol; 2019 Mar; 36(2):236-241. PubMed ID: 30762246
[TBL] [Abstract][Full Text] [Related]
20. Combined treatment with immunoadsorption and rituximab leads to fast and prolonged clinical remission in difficult-to-treat pemphigus vulgaris.
Behzad M; Möbs C; Kneisel A; Möller M; Hoyer J; Hertl M; Eming R
Br J Dermatol; 2012 Apr; 166(4):844-52. PubMed ID: 22092243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
